Multiple intravenous antibiotics usage is associated with intravenous immunoglobulin resistance in Kawasaki disease

Zon-Min Lee1, Chiao-Lun Chu2, Chi-Hsiang Chu3

  • 1Department of Pharmacy, Kaohsiung Chang Gung Memorial Hospital, Taiwan.

Insights

Antibiotic use in children with Kawasaki disease (KD) may increase resistance to immunoglobulin (IVIG) treatment. Multiple antibiotic use correlated with higher IVIG resistance rates, suggesting cautious prescription for suspected infections.

Area of Science:

  • Pediatrics
  • Rheumatology
  • Infectious Diseases

Background:

  • Kawasaki disease (KD) is a critical vasculitis affecting young children.
  • Antibiotics are frequently given to KD patients before diagnosis due to fever and inflammation.
  • The impact of antibiotic exposure on KD treatment outcomes requires investigation.

Purpose of the Study:

  • To determine how antibiotic usage affects the treatment outcomes of Kawasaki disease.
  • To analyze the relationship between antibiotic administration and immunoglobulin (IVIG) resistance in KD patients.

Main Methods:

  • Retrospective chart review of 280 children diagnosed with KD between 2005 and 2017.
  • Exclusion of KD patients receiving initial IVIG treatment more than 10 days after symptom onset.
  • Comparison of IVIG resistance rates among non-antibiotic users, single-antibiotic users, and multiple-antibiotic users.

Main Results:

  • Children receiving multiple antibiotics showed significantly higher IVIG resistance rates (21.6%) compared to non-users (5.6%) and single-drug users (8.9%).
  • Increased C-reactive protein (CRP) levels correlated with a higher likelihood of IVIG resistance (p < 0.001).
  • White blood cell (WBC) count did not show a significant association with IVIG resistance (p = 0.466).

Conclusions:

  • The use of multiple intravenous antibiotics in Kawasaki disease patients is associated with increased IVIG resistance.
  • Elevated CRP levels are a predictor of IVIG resistance in KD.
  • Physicians should exercise caution when prescribing multiple antibiotics for presumed infections in KD patients to optimize treatment outcomes.
Abstract

Related Concept Videos

Drug Accumulation During Multiple Dosing: Intermittent IV Infusions01:24

Drug Accumulation During Multiple Dosing: Intermittent IV Infusions

Intermittent intravenous (IV) infusion is a method of drug administration where medications are delivered over short infusion periods followed by intervals of no drug delivery. This approach helps to prevent sustained high drug concentrations in the bloodstream, reducing the risk of adverse effects associated with prolonged exposure. Unlike continuous infusion, steady-state concentrations may not be achieved during a single dosing cycle but can be reached through repeated...
26
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence01:22

Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence

Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...
21
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
82
Estimation of k and VD of Aminoglycosides01:20

Estimation of k and VD of Aminoglycosides

Aminoglycosides are a class of antibiotics used to treat various bacterial infections. Clinicians must determine the elimination rate constant (k) and volume of distribution (VD) to optimize therapeutic efficacy and minimize toxicity. The k value represents the rate at which the drug is removed from the body, and the VD reflects the degree to which the drug distributes into body tissues. Accurately estimating these parameters allows healthcare professionals to tailor drug dosing to individual...
25
Dosage Interval and Administration Route: Determination Methods01:19

Dosage Interval and Administration Route: Determination Methods

A medication’s effectiveness largely depends on its appropriate dosage and the route of administration. Dosage ensures that a sufficient drug concentration is maintained in the bloodstream to elicit the desired therapeutic effect without causing toxicity. The route of administration affects the drug's bioavailability, rate of absorption, and onset of action, which are crucial for achieving optimal therapeutic outcomes. Drug dosage calculations are critical to tailoring therapy to...
22
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations01:15

Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations

Gentamicin, an aminoglycoside antibiotic, is commonly administered via intermittent intravenous infusion to treat severe infections. An intermittent one-hour infusion of gentamicin, administered at eight-hour intervals, allows for precise control of plasma drug concentrations, minimizing toxicity while ensuring therapeutic efficacy. Pharmacokinetic principles govern the dynamics of plasma concentrations and can be mathematically described using specific equations.The plasma drug concentration...
18